Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients
Author(s) -
KookHwan Oh,
Ji Yong Jung,
Myeong Ok Yoon,
Ahui Song,
H. Lee,
Han Ro,
YoungHwan Hwang,
Dong Ki Kim,
Peter J. Margetts,
Curie Ahn
Publication year - 2010
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfp670
Subject(s) - medicine , peritoneal equilibration test , peritoneal dialysis , endocrinology , peritonitis , peritoneal cavity , inflammation , creatinine , angiogenesis , renal function , gastroenterology , albumin , surgery , continuous ambulatory peritoneal dialysis
Interleukin-6 (IL-6) is a key player in modulating inflammation. IL-6 and soluble IL-6 receptor (sIL-6R) complex induces the synthesis and secretion of various chemokines, adhesion molecules and angiogenic molecules. We hypothesized that the baseline peritoneal solute transport rate (PSTR) early after commencing peritoneal dialysis (PD) may depend largely on the IL-6/sIL-6R system. We also hypothesized that the dialysate concentrations of IL-6/sIL-6R could be closely related to local inflammation or angiogenesis in the peritoneal cavity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom